Wright Medical will pay $190 million in cash and stock for BioMimetic, which produces regenerative medicine products for bone and tissue repair. Contingent payments of up to $190 million may be made, pending FDA approval of a new BioMimetic product.
More Articles on Devices:
Smith & Nephew Appoints Julie Brown as CFO
Medtronic Acquires Chinese Orthopedic Device Company for $755M
24 Spine Devices Receive FDA 510(k) Clearance in October
Wright Medical Group to Buy BioMimetic for About $380M FeaturedWritten by Heather Linder | Tuesday, 20 November 2012 17:53
Medical device manufacturer Wright Medical Group has agreed to purchase BioMimetic Therapeutics for up to $380 million, according to Memphis Business Journal.
© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies here.
New from Becker's Orthopedic & Spine Review